Your browser is no longer supported. Please, upgrade your browser.
Settings
INFI Infinity Pharmaceuticals, Inc. daily Stock Chart
INFI [NASD]
Infinity Pharmaceuticals, Inc.
Index- P/E1.41 EPS (ttm)1.25 Insider Own1.10% Shs Outstand60.33M Perf Week-2.22%
Market Cap106.18M Forward P/E- EPS next Y-0.97 Insider Trans398.68% Shs Float55.24M Perf Month3.53%
Income64.10M PEG- EPS next Q-0.07 Inst Own54.90% Short Float1.39% Perf Quarter54.39%
Sales22.00M P/S4.83 EPS this Y-131.50% Inst Trans3.38% Short Ratio3.01 Perf Half Y-23.81%
Book/sh0.92 P/B1.91 EPS next Y-37.10% ROA-19.80% Target Price2.75 Perf Year-30.71%
Cash/sh0.97 P/C1.81 EPS next 5Y- ROE-22.20% 52W Range1.00 - 2.92 Perf YTD49.15%
Dividend- P/FCF- EPS past 5Y40.20% ROI-22.70% 52W High-39.73% Beta2.20
Dividend %- Quick Ratio7.80 Sales past 5Y- Gross Margin- 52W Low76.00% ATR0.15
Employees25 Current Ratio7.80 Sales Q/Q- Oper. Margin-54.40% RSI (14)59.92 Volatility5.93% 9.89%
OptionableYes Debt/Eq0.00 EPS Q/Q-110.90% Profit Margin-51.20% Rel Volume1.11 Prev Close1.72
ShortableYes LT Debt/Eq0.00 EarningsMar 14 BMO Payout- Avg Volume254.64K Price1.76
Recom3.00 SMA206.73% SMA5022.28% SMA200-1.50% Volume282,850 Change2.33%
Jan-04-19Initiated B. Riley FBR Buy $3
Nov-12-18Downgrade Wells Fargo Outperform → Market Perform
Nov-12-18Downgrade JP Morgan Neutral → Underweight
Oct-12-17Upgrade Wells Fargo Market Perform → Outperform
Aug-10-16Reiterated Wedbush Neutral $1.25 → $1
Jun-15-16Downgrade Wells Fargo Outperform → Market Perform
Jun-15-16Downgrade RBC Capital Mkts Outperform → Sector Perform $12 → $2
Jun-15-16Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-15-16Downgrade Jefferies Buy → Hold
Jun-14-16Downgrade JP Morgan Overweight → Neutral
Jun-14-16Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-14-16Downgrade FBR Capital Outperform → Mkt Perform $15 → $2
Mar-02-16Initiated FBR Capital Outperform $15
Feb-25-16Reiterated Wedbush Neutral $9 → $8
Sep-21-15Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-07-15Reiterated RBC Capital Mkts Outperform $18 → $15
May-07-15Initiated Deutsche Bank Buy $20
Oct-20-14Resumed Stifel Hold
Mar-06-13Reiterated Stifel Buy $39 → $50
Mar-06-13Reiterated RBC Capital Mkts Outperform $38 → $55
Mar-22-19 10:10PM  Edited Transcript of INFI earnings conference call or presentation 14-Mar-19 12:00pm GMT Thomson Reuters StreetEvents
Mar-18-19 11:26AM  Karyopharm Stock Up Even as FDA Delays Selinexor NDA Verdict Zacks
09:22AM  Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down Zacks
Mar-15-19 11:37AM  Infinity Inks Deal With Roche for Phase II Study of IPI-549 Zacks -5.76%
Mar-14-19 09:50AM  Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates Zacks +24.03%
08:52AM  Infinity: 4Q Earnings Snapshot Associated Press
07:32AM  Infinity Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Company Update PR Newswire
07:02AM  Infinity To Initiate MARIO-3, A Phase 2 Multi-Arm Study Evaluating IPI-549 In Front-Line Triple Negative Breast Cancer And Renal Cell Cancer PR Newswire
05:00AM  Infinity Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-07-19 04:05PM  Infinity Announces the Date of Its Full Year 2018 Financial Results Conference Call and Webcast PR Newswire -9.36%
Mar-06-19 07:32AM  Infinity Pharmaceuticals Announces Royalty Monetization of COPIKTRA for $30 Million Gross Proceeds PR Newswire
Feb-06-19 07:55AM  Analysis: Positioning to Benefit within Conagra Brands, National Retail Properties, PRA Health Sciences, Westinghouse Air Brake Technologies, YRC Worldwide, and Infinity Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-04-19 08:32AM  Infinity Pharmaceuticals To Present At BIO CEO & Investor Conference PR Newswire
Jan-07-19 07:32AM  Infinity Pharmaceuticals Provides 2019 Goals and Financial Guidance PR Newswire +8.87%
Jan-03-19 04:05PM  Infinity To Present At 37th Annual J.P. Morgan Healthcare Conference PR Newswire -5.60%
Dec-05-18 09:30AM  Infinity (INFI) Down 48.3% Since Last Earnings Report: Can It Rebound? Zacks
Nov-13-18 07:26AM  Edited Transcript of INFI earnings conference call or presentation 5-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
06:55AM  Todays Research Reports on Stocks to Watch: Infinity Pharmaceuticals and athenahealth ACCESSWIRE
Nov-10-18 06:02AM  Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd Annual Meeting PR Newswire
Nov-09-18 08:35AM  Detailed Research: Economic Perspectives on MetLife, Callon Petroleum, Five9, Ballard Power, Infinity Pharmaceuticals, and Commercial Vehicle Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-07-18 10:50AM  Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer Zacks +6.41%
Nov-06-18 03:24PM  Infinity (INFI) Q3 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Nov-05-18 04:55PM  Infinity: 3Q Earnings Snapshot Associated Press
04:03PM  Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results PR Newswire
06:59AM  Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer PR Newswire
06:59AM  Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer Business Wire
Nov-01-18 02:23PM  Infinity Announces IPI-549 Late-Breaking Presentation at SITC 33rd Annual Meeting PR Newswire +17.50%
Oct-29-18 08:32AM  Infinity Announces the Date of Its Third Quarter 2018 Financial Results Conference Call and Webcast PR Newswire -5.09%
Oct-17-18 07:55AM  Report: Exploring Fundamental Drivers Behind Infinity Pharmaceuticals, AxoGen, MUELLER WATER PRODUCTS, MYR Group, RealNetworks, and Odonate Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-11-18 08:32AM  Infinity To Present At BIO Investor Forum PR Newswire
Oct-03-18 08:40AM  Infinity Pharmaceuticals (INFI) Looks Good: Stock Adds 6.5% in Session Zacks
Oct-02-18 08:38AM  The Zacks Analyst Blog Highlights: Champions Oncology, CytoDyn, Infinity Pharmaceuticals, Nektar Therapeutics and Zoetis Zacks +6.51%
Oct-01-18 10:28AM  5 Best Biotech Stocks to Buy In October Zacks
08:32AM  Infinity Pharmaceuticals Earns $22 Million Payment From Verastem Oncology For FDA Approval Of COPIKTRA (duvelisib) And Updates 2018 Financial Guidance PR Newswire
Sep-27-18 05:11PM  /C O R R E C T I O N -- Infinity Pharmaceuticals, Inc./ PR Newswire
Sep-26-18 08:45AM  Options Traders Expect Huge Moves in Infinity (INFI) Stock Zacks
08:32AM  Infinity To Present At Cantor Fitzgerald Global Healthcare Conference PR Newswire
Sep-06-18 11:24AM  Infinity (INFI) Up 21.9% Since Last Earnings Report: Can It Continue? Zacks
Aug-28-18 08:32AM  Infinity To Present At Three Upcoming Investor Conferences In September PR Newswire
Aug-22-18 08:55AM  Infinity Focuses on Developing IPI-549 for Solid Tumors Zacks
08:00AM  Research Report Identifies America's Car-Mart, SAExploration, Ascena Retail Group, Infinity Pharmaceuticals, Hologic, and California Resources with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-17-18 01:40PM  Edited Transcript of INFI earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-18 09:27AM  Infinity (INFI) Posts Narrower-Than-Expected Loss in Q2 Zacks
Aug-07-18 05:26PM  Infinity: 2Q Earnings Snapshot Associated Press
04:05PM  Infinity Pharmaceuticals Provides Company Update and Second Quarter 2018 Financial Results PR Newswire
02:30PM  Infinity Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
08:30AM  Infinity Pharmaceuticals Appoints Samuel Agresta, M.D., M.P.H. as Chief Medical Officer PR Newswire
Aug-03-18 03:09PM  Why Boston and central Texas have so many of the best-paying companies in the U.S. Here's where other cities are missing out. American City Business Journals
Jul-31-18 04:05PM  Infinity Announces The Date Of Its Second Quarter 2018 Financial Results Conference Call And Webcast PR Newswire
Jul-13-18 07:30AM  Free Technical Research on Insmed and Three More Biotech Equities ACCESSWIRE
Jun-27-18 06:39PM  Infinity and Arcus Ink Deal for Two Triple Combo Studies Zacks
Jun-26-18 08:30AM  Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies PR Newswire
Jun-25-18 08:40AM  Is the Options Market Predicting a Spike in Infinity (INFI) Stock? Zacks
Jun-12-18 07:45AM  New Research: Key Drivers of Growth for CNA Financial, AutoNation, Hess, Infinity Pharmaceuticals, Regulus Therapeutics, and Weyerhaeuser Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire -5.41%
Jun-07-18 09:33AM  Infinity Pharmaceuticals (INFI) Down 6.7% Since Earnings Report: Can It Rebound? Zacks
Jun-04-18 07:30AM  Infinity Reports IPI-549 Clinical and Translational Data from Ongoing Phase 1/1b Study at American Society of Clinical Oncology Annual Meeting PR Newswire -7.96%
May-22-18 08:30AM  Serametrix MDSC Assay Being Utilized By Infinity Pharmaceuticals in the First Clinical Study to Prospectively Identify Patients With High Blood Levels of MDSCs Business Wire
May-11-18 09:36PM  Edited Transcript of INFI earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-09-18 02:12PM  Infinity (INFI) Incurs In-Line Loss in Q1, Maintains View Zacks
May-08-18 06:04PM  Infinity: 1Q Earnings Snapshot Associated Press -5.45%
04:07PM  Infinity Announces Presentations On IPI-549 At Upcoming American Society of Clinical Oncology Annual Meeting PR Newswire
04:05PM  Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results PR Newswire
May-03-18 11:39AM  Acorda (ACOR) Q1 Earnings Miss Estimates, Sales Down Y/Y Zacks
May-01-18 04:05PM  Infinity Announces The Date Of Its First Quarter 2018 Financial Results Conference Call And Webcast PR Newswire
Apr-27-18 12:19PM  Medicines Company's (MDCO) Q1 Loss Widens, Revenues Tank Y/Y Zacks
Apr-16-18 03:06AM  Why Is Infinity Pharmaceuticals (INFI) Down 18.3% Since its Last Earnings Report? Zacks
Apr-12-18 09:38AM  Why Infinity Pharmaceuticals (INFI) Could Shock the Market Soon Zacks +9.80%
Apr-11-18 11:56AM  Karyopharm's Myeloma Candidate Gets Fast Track Designation Zacks
Mar-28-18 08:41AM  Are Options Traders Betting on a Big Move in Infinity Pharmaceuticals (INFI) Stock? Zacks
Mar-26-18 08:32AM  Infinity to Present at Two Upcoming Conferences PR Newswire
Mar-22-18 05:54AM  Can The Uptrend Continue for Infinity Pharmaceuticals (INFI)? Zacks
Mar-21-18 11:36AM  Infinity To Present At BioCentury's 25th Annual Future Leaders In The Biotech Industry Conference PR Newswire
Mar-16-18 06:36PM  Infinity (INFI) Reports Narrower-than-Expected Loss in Q4 Zacks -5.47%
05:16PM  Edited Transcript of INFI earnings conference call or presentation 15-Mar-18 8:30pm GMT Thomson Reuters StreetEvents
Mar-15-18 04:27PM  Infinity reports 4Q loss Associated Press
04:05PM  Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results PR Newswire
12:30PM  Infinity Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-08-18 04:05PM  Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast PR Newswire
08:32AM  Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board PR Newswire
Feb-16-18 07:45AM  Research Report Identifies TESARO, Brunswick, Brooks Automation, Infinity Pharmaceuticals, Edison International, and Anthem with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-05-18 08:32AM  Infinity To Present At BIO CEO & Investor Conference PR Newswire
Jan-26-18 09:15AM  Infinity Provides Update on Lead Candidate, Issues 2018 View Zacks
Jan-08-18 08:32AM  Infinity Provides Update on IPI-549 Phase 1/1b Study, 2018 Goals and Financial Guidance PR Newswire -10.18%
Jan-05-18 08:32AM  Infinity To Present At 36th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-07-17 12:23PM  Ismailia National Food Industries : Fairly valued, but dont skip the other factors Capital Cube +15.79%
Dec-01-17 08:00AM  Market Trends Toward New Normal in Infinity Pharmaceuticals, Edison International, Anthem, TESARO, Brunswick, and BroadSoft Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-18-17 04:30PM  Edited Transcript of INFI earnings conference call or presentation 7-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Nov-14-17 08:43AM  Options Traders Expect Huge Moves in Infinity Pharmaceuticals (INFI) Stock Zacks
Nov-13-17 08:10AM  Todays Research Reports on Stocks to Watch: Infinity Pharmaceuticals and Synergy Pharmaceuticals ACCESSWIRE -13.28%
07:50AM  Featured Company News - Infinity Shares Clinical and Translational Data from Monotherapy Dose-Escalation Component of Phase-1/1b Study for IPI-549 ACCESSWIRE
Nov-10-17 04:36PM  Edited Transcript of INFI earnings conference call or presentation 9-May-17 8:30pm GMT Thomson Reuters StreetEvents -13.93%
05:32AM  Infinity Pharmaceuticals Reports IPI-549 Clinical and Translational Data from Completed Monotherapy Dose-Escalation Component of Phase 1/1b Clinical Study in Patients with Advanced Solid Tumors at SITC Annual Meeting PR Newswire
Nov-08-17 10:12AM  Infinity (INFI) Q3 Loss Narrower than Expected, View Intact Zacks
Nov-07-17 08:09AM  Infinity reports 3Q loss Associated Press
08:01AM  Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results PR Newswire
Nov-06-17 08:02AM  Infinity to Host Investor Reception and Webcast at SITC PR Newswire
Nov-01-17 08:20AM  New Research: Key Drivers of Growth for Antares Pharma, Infinity Pharma, Inotek Pharma, Hostess Brands, Arconic, and Enterprise Products - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire -5.58%
Oct-30-17 08:32AM  Infinity Announces the Date of Its Third Quarter 2017 Financial Results Conference Call and Webcast PR Newswire
Oct-23-17 08:10AM  Infinity, Wells Fargo Upgrade, SITC Meeting in November, IPI-549 Update ACCESSWIRE
Oct-13-17 08:00AM  Today's Research Reports on Trending Tickers: Antares Pharma and Infinity Pharmaceuticals ACCESSWIRE -22.25%
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, develops medicines for people with cancer in the United States. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma (PI3K-gamma), which is in Phase 1/1b clinical study. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib, as well as duvelisib program, including DUO study that is in randomized and monotherapy Phase III clinical study for patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma; PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate; and AbbVie Inc. to develop and commercialize products containing duvelisib in oncology indications., as well as collaboration agreements with Arcus Biosciences, Inc. and Bristol-Myers Squibb Company. Infinity Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BVF PARTNERS L P/IL10% OwnerDec 13Buy1.20175,000209,9138,485,575Dec 17 07:40 PM
BVF PARTNERS L P/IL10% OwnerNov 28Buy1.30100,000130,0006,510,597Nov 30 06:28 PM
BVF PARTNERS L P/IL10% OwnerNov 21Buy1.354,7006,3458,431,114Nov 21 05:57 PM
BVF PARTNERS L P/IL10% OwnerNov 19Buy1.371,465,1262,005,0768,426,995Nov 21 05:57 PM
BVF PARTNERS L P/IL10% OwnerNov 15Buy1.3591,474123,4907,643,800Nov 15 08:07 PM
BVF PARTNERS L P/IL10% OwnerNov 14Buy1.34210,250281,7357,591,400Nov 15 08:07 PM
BVF PARTNERS L P/IL10% OwnerNov 13Buy1.35604,208815,6817,474,110Nov 15 08:07 PM
Perkins Adelene QChief Executive OfficerOct 01Sale2.825,00014,100609,561Oct 02 04:30 PM
Kutok JefferyChief Scientific OfficerAug 16Sale2.006,13312,2660Aug 17 04:05 PM
Kutok JefferyChief Scientific OfficerAug 15Sale2.018,18016,4216,133Aug 17 04:05 PM
Kutok JefferyChief Scientific OfficerJun 22Sale2.0014,31328,69514,313Jun 25 05:00 PM
BVF PARTNERS L P/IL10% OwnerJun 21Buy1.65425,531702,1267,432,656Jun 21 06:57 PM
BVF PARTNERS L P/IL10% OwnerJun 19Buy1.653,516,5605,802,3247,202,101Jun 21 06:57 PM
BVF PARTNERS L P/IL10% OwnerApr 10Buy2.001,010,0002,020,0005,285,341Apr 11 06:01 PM
BVF PARTNERS L P/IL10% OwnerApr 09Buy1.90500,000950,0004,738,476Apr 11 06:01 PM